CLNN (Clene Inc. Common Stock) Stock Analysis - AI Report

Clene Inc. Common Stock (CLNN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLNN trades at $6.72 with a market cap of $86.76M and a P/E ratio of -1.19. CLNN moved +7.60% today. Year to date, CLNN is +19.79%; over the trailing twelve months it is +165.38%. Its 52-week range spans $2.28 to $13.50. Analyst consensus is strong buy with an average price target of $32.20. Rallies surfaces CLNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on CLNN?

Rallies AI research for CLNN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

CLNN Key Metrics

Key financial metrics for CLNN
MetricValue
Price$6.72
Market Cap$86.76M
P/E Ratio-1.19
EPS$-5.67
Dividend Yield0.00%
52-Week High$13.50
52-Week Low$2.28
Volume201
Avg Volume0
Revenue (TTM)$342.00K
Net Income$-39.40M
Gross Margin79.53%

Latest CLNN News

Recent CLNN Insider Trades

  • Ugwumba Chidozie sold 73.30K (~$454.44K) on May 12, 2026.
  • Ugwumba Chidozie sold 22.18K (~$149.69K) on May 11, 2026.
  • Ugwumba Chidozie sold 72.88K (~$495.61K) on May 4, 2026.

CLNN Analyst Consensus

5 analysts cover CLNN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.20.

Common questions about CLNN

What is the AI research view on CLNN?
Rallies AI research for CLNN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for CLNN?
Rallies AI research for CLNN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is CLNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLNN. It does not provide personalized investment advice.
CLNN

CLNN